NCT06151223RecruitingAccepts Healthy Volunteers
A Prospective Registry for Patients at High-Risk for Pancreatic Cancer
Mayo Clinic
Start Date
7/13/2021
Completion Date
7/31/2031
Summary
This study aims to facilitate discovery and validation of tests for early detection in subjects at high risk for pancreatic ductal adenocarcinoma (PDAC) and to facilitate the use of state-of-the-art machine learning-based algorithms that utilize databases and images with the purpose of identifying early stages of pancreatic cancer, as well as people at high-risk.The study also aims to provide a platform for development of an interventional protocol for early detection of PDAC.
Eligibility Criteria
Age Range: 18 years to No maximum
Inclusion Criteria:
* Age ≥ 18 year
* Able to provide written informed consent
* Meets criteria as a High-Risk Individual as defined by protocol
Exclusion Criteria:
* Individual who has a personal history of pancreatic ductal adenocarcinoma (PDAC)
* History of total pancreatectomy
Interventions
OTHER
Bio-specimen Collection: Blood
OTHER
Bio-specimen Collection: Pancreatic Juice
DIAGNOSTIC_TEST
MRI
Conditions
Pancreatic CancerPancreatic Ductal AdenocarcinomaPDACPDAC - Pancreatic Ductal Adenocarcinoma
Locations
Mayo Clinic in Rochester
Rochester, Minnesota 55905
United States